Avid Bioservices Inc (CDMO)

[north40000]

Your question that I asked originally at Wistar, and renewed in Baltimore, stemmed I think from the MSKCC/PPHM November SITC 2016 poster/abstract—that poster, explicitly, had little or nothing to do with CAR-T therapy then, did it?

The poster #1651 relating to PPHM, MSKCC and Bavi family role in CAR-T therapy first appeared at AACR 2017 in April.

I enjoy international chess matches. Your move.

So far, we are even—either alternative is possible for design of a human clinical trial.

BTW, I have a further observation gleaned from a different 2017 SITC poster that may be worth further discussion....later.